Rybelsus, a groundbreaking oral medication for type 2 diabetes, has stirred significant attention in the healthcare arena, primarily due to its pricing structure. Slated at an average retail cost of around $800 to $900 for a 30-day supply, this price raises eyebrows when compared to traditional injectables. Patients facing diabetes…